{"denoms":[{"counts":[{"groupId":"OG000","value":"0"}],"units":"Participants"}],"groups":[{"description":"doxorubicin hydrochloride: given as 25mgm2 IV on days 1 and 8 of each 21-day cycle.\n\ngemcitabine hydrochloride: given as 100mg/m2 IV over days 1 and 8 of each 21 day cycle","id":"OG000","title":"Gemcitabine+Doxorubicin"}],"populationDescription":"data for this endpoint was not collected","reportingStatus":"POSTED","timeFrame":"Every 6 weeks for up to 8 months","title":"Duration of Response","type":"SECONDARY"}